Acute and chronic effects of dietary sodium restriction on renal tubulointerstitial fibrosis in cisplatin-treated rats

Nephrology Dialysis Transplantation

Volumn 28, Issue 3, 2013, Pages 592-602

  Park, Joon Sung ^a   Jo, Chor Ho ^a   Kim, Sua ^a   Kim, Gheun Ho ^a  

^a Hanyang University   (South Korea)

Author keywords

Cisplatin; Epithelial mesenchymal transition; Fibrosis; Low sodium diet; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CISPLATIN; COLLAGEN TYPE 3; FIBRONECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL INFILTRATION; CELL INVASION; CONTROLLED STUDY; EPITHELIUM CELL; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RENAL TUBULOINTERSTITIAL FIBROSIS; SINGLE DRUG DOSE; SODIUM RESTRICTION; TUBULOINTERSTITIAL INJURY;

ACUTE DISEASE; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHRONIC DISEASE; CISPLATIN; DIET, SODIUM-RESTRICTED; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; IMMUNOENZYME TECHNIQUES; KIDNEY TUBULES; MALE; NEPHRITIS, INTERSTITIAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84874823517     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs496     Document Type: Article

References (43)

1. Takada K, Kawamura T, Inai M et al. Pharmacokinetics of cisplatin in analbuminemic rats. Biopharm Drug Dispos 1999; 20: 421-428
2. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008; 73: 994-1007
3. Hartmann JT, Kollmannsberger C, Kanz L et al. Platinum organ toxicity and possible prevention in patients with testicular cancer. Int J Cancer 1999; 83: 866-869
4. Yang T, Vesey DA, Johnson DW et al. Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies. Transl Res 2007; 150: 40-50
5. Yamamato E, Izawa T, Juniantito V et al. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions. Histol Histopathol 2010; 25: 995-1007
6. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12
7. Fogo AB. Regression lines in chronic kidney disease. Am Soc Nephrol 2003; 14: 2990-2991
8. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 353-365
9. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292
10. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222
11. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522-3530
12. Xu Y, Wan J, Jiang D et al. BMP-7 counteracts TGFbeta1- induced epithelial-to-mesenchymal transition in human renal proximal tubular epithelial cells. J Nephrol 2009; 22: 403-410
13. Pletinck A, Consoli C, Van Landschoot M et al. Salt intake induces epithelial-to-mesenchymal transition of the peritoneal membrane in rats. Nephrol Dial Transplant 2010; 25: 1688-1696
14. Krikken JA, Laverman GD, Navis G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens 2009; 18: 531-538
15. Yu HC, Burrell LM, Black MJ et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998; 98: 2621-2628
16. Dworkin LD, Benstein JA, Tolbert E et al. Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol 1996; 7: 437-442
17. Vogt L, Waanders F, Boomsma F et al. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 2008; 19: 999-1007
18. Benstein JA, Feiner HD, Parker M et al. Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol 1990; 258: F1675-F1681
19. Ritz E, Mehls O. Salt restriction in kidney disease - a missed therapeutic opportunity? Pediatr Nephrol 2009; 24: 9-17
20. Sowers Jr. Hypertension, angiotensin II, and oxidative stress. N Engl J Med 2002; 346: 1999-2001
21. Nangaku M, Pippin J, Couser WG. C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 2002; 13: 928-936
22. Yu XQ, Wu LL, Huang XR et al. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Kidney Int 2000; 58: 1469-1480
23. Lee CH, Kim S, Kang CM et al. Altered expression of tight junction proteins in cyclosporine nephrotoxicity. Am J Nephrol 2011; 33: 7-16
24. Yamate J, Sato K, Ide M et al. Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats. Vet Pathol 2002; 39: 322-333
25. Razzaque MS. Cisplatin nephropathy: is cytotoxicity avoidable? Nephrol Dial Transplant 2007; 22: 2112-2116
26. Tesch GH, Schwarting A, Kinoshita K et al. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999; 103: 73-80
27. Roncal CA, Mu W, Croker B et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2007; 292: F116-F122
28. Vernon MA, Mylonas KJ, Hughes J. Macrophages and renal fibrosis. Semin Nephrol 2010; 30: 302-317
29. Denhardt DT, Noda M, O'Regan AW et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055-1061
30. Iguchi S, Nishi S, Ikegame M et al. Expression of osteopontin in cisplatin-induced tubular injury. Nephron Exp Nephrol 2004; 97: e96-e105
31. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428
32. Roberts AB, Tian F, Byfield SD et al. Smad3 is key to TGF-β- mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 2006; 17: 19-27
33. Wang A, Ziyadeh FN, Lee EY et al. Interference with TGF-β signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am J Physiol Renal Physiol 2007; 293: F1657-F1665
34. Yamate J, Machida Y, Ide M et al. Cisplatin-induced renal interstitial fibrosis in neonatal rats, developing as solitary nephron unit lesions. Toxicol Pathol 2005; 33: 207-217
35. Yamate J, Kuribayashi M, Kuwamura M et al. Differential immunoexpressions of cytoskeletons in renal epithelial and interstitial cells in rat and canine fibrotic kidneys, and in kidneyrelated cell lines under fibrogenic stimuli. Exp Toxicol Pathol 2005; 57: 135-147
36. Rosón MI, Cavallero S, Della Penna S et al. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney Int 2006; 70: 1439-1446
37. Jones-Burton C, Mishra SI, Fink JC et al. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol 2006; 26: 268-275
38. Ritz E, Dikow R, Morath C et al. Salt - a potential 'uremic toxin'? Blood Purif 2006; 24: 63-66
39. Mishra SI, Jones-Burton C, Fink JC et al. Does dietary salt increase the risk for progression of kidney disease? Curr Hypertens Rep 2005; 7: 385-391
40. Weir MR, Fink JC. Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. Am J Kidney Dis 2005; 45: 176-188
41. Hovater MB, Sanders PW. Effect of dietary salt on regulation of TGF-β in the kidney. Semin Nephrol 2012; 32: 269-276
42. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004; 43: 142-146
43. Hamming I, Navis G, Kocks MJ et al. ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats. J Pathol 2006; 209: 129-139